Worldwide Prevalence of Social Anxiety Disorders 2019-2029 by Ethnicity & Geography

DUBLIN, Feb. 12, 2020 /PRNewswire/ -- The "Prevalence of Social Anxiety Disorder in 27 Major Markets 2019-2029" report has been added to's offering.

This report provides the current prevalence of Social Anxiety Disorder (SAD) across 28 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Brazil, Japan, China, Turkey, Mexico, Denmark, Egypt and South Korea, Argentina, Australia, Sweden, Denmark, Norway, Finland, The Netherlands, Poland, Russia, Switzerland, Austria) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Social Anxiety Disorder (SAD) have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for the disease include:

    --  Feel nauseous or sick
    --  Presence of rigid body posture, very little eye contact
    --  Blush, sweat, tremble and a rapid heart rate
    --  Self-conscious in front of other people and feel embarrassed or awkward
    --  Panic attacks, where you have an overwhelming fear and anxiety
    --  Clinical depression
    --  Alcohol use disorders

Reason to buy:

    --  Able to quantify patient populations in global Social Anxiety Disorder
        market to target the development of future products, pricing strategies
        and launch plans.
    --  Gain further insight into the incidence of the subdivided populations of
        Social Anxiety Disorder and identify patient segments with high
    --  Delivery of more accurate information for clinical trials in study
        sizing and realistic patient recruitment for various countries.
    --  Provide a level of understanding on the impact from specific co-morbid
        conditions on Social Anxiety Disorder prevalence
    --  Identify sub-populations within SAD populations which require treatment.
    --  Gain an understanding of the specific markets that have the largest
        number Social Anxiety patients.

Key Topics Covered

    1. Introduction
    2. Cause Of The Disease
    3. Risk Factors & Prevention
    4. Diagnosis Of The Disease
    5. Variation By Geography/Ethnicity
    6. Disease Prognosis & Clinical Course
    7. Key Comorbid Conditions/Features Associated With The Disease
    8. Methodology For Quantification Of Patient Numbers
    9. Additional Data Available On Request
    10. Top-Line Prevalence For Social Anxiety Disorder
    11. Features Of Social Anxiety Disorder Patients
    12. Kessler Distress Scale Use In Social Anxiety Patients
    13. Age Onset In Social Anxiety Patients
    14. Sheelam Disability Scaled In Social Anxiety Patients
    15. Abbreviations Used In The Report
    16. Other Services & Solutions
    17. Reports & Publications
    18. Online Epidemiology Databases
    19. Online Pharmaceutical Pricing Database

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets